Comparison of different approaches to predict metabolic drug–drug interactions

By Einolf H. J.  

Xenobiotica, Vol. 37, Iss. 10-11, 2007-06 ,pp. : 1257-1294

Informa Healthcare

Access to resources Recommend Favorite

CYP Inhibition-Mediated Drug-Drug Interactions

By  

Current Enzyme Inhibition, Vol. 6, Iss. 3, 2010-10 ,pp. : 130-145

Bentham Science Publishers

Access to resources Recommend Favorite

Studies on the metabolic fate of M17055, a novel diuretic (6). Assessment for drug-drug interactions of M17055 in metabolism, distribution and excretion

By Nakajima H.   Nakanishi T.   Naba H.   Nakai K.   Matsumoto S.   Nagasawa K.   Ida K.   Ogihara T.   Ohzawa N.  

Xenobiotica, Vol. 32, Iss. 12, 2002-12 ,pp. : 1161-1172

Informa Healthcare

Access to resources Recommend Favorite

A simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data

By Rioux Nathalie   Batonga Joëlle   Colombo Federico   Massé Jonathan   Zouki Christine   Ribadeneira Maria D.   Duan Jianmin   Bethell Richard C.  

Xenobiotica, Vol. 43, Iss. 7, 2013-07 ,pp. : 592-597

Informa Healthcare

Access to resources Recommend Favorite

Effect of cationic drugs on the transporting activity of human and rat OCT/Oct 1-3 in vitro and implications for drug-drug interactions

By Umehara K. -I.   Iwatsubo T.   Noguchi K.   Usui T.   Kamimura H.  

Xenobiotica, Vol. 38, Iss. 9, 2008-09 ,pp. : 1203-1218

Informa Healthcare

Access to resources Recommend Favorite